OM · Outset Medical, Inc. · Documents

Nov 6

Earnings call

Q3 2024 earnings call

Nov 6

Current report 8-K

Financial results

Sep 27

Current report 8-K Events of Sep 23

Delisting notice or listing transfer

Aug 16

Current report 8-K Events of Aug 15

Director or officer change, or executive pay

Aug 8

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $27.39M ▼ 24.0% Net loss $34.45M Diluted EPS -$0.66

Aug 7

Earnings call

Q2 2024 earnings call

Aug 7

Current report 8-K

Financial results

May 30

Current report 8-K Events of May 29

Shareholder vote results

May 9

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $28.17M ▼ 15.8% Net loss $39.94M Diluted EPS -$0.78

May 8

Earnings call

Q1 2024 earnings call

May 8

Current report 8-K

Financial results, Director or officer change, or executive pay, Other events

May 6

Current report 8-K

Other events

Apr 11

Proxy statement DEF 14A Meeting May 29, 2024

Proxy statement

Apr 11

Proxy statement DEFA14A

Proxy statement

Mar 13

Current report 8-K Events of Mar 8

Director or officer change, or executive pay, Regulation FD disclosure

Feb 21

Earnings call

Q4 2023 earnings call

Feb 21

Current report 8-K Events of Feb 16

Financial results, Director or officer change, or executive pay

Feb 21

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $130.38M ▲ 13.0% Net loss $172.8M Diluted EPS -$3.48

Jan 8

Current report 8-K

Financial results, Regulation FD disclosure

Jan 2

Current report 8-K

New debt or off-balance-sheet obligation

Dec 11

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation

Nov 8

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $30.36M ▲ 9.4% Net loss $46.18M Diluted EPS -$0.93

Nov 7

Earnings call

Q3 2023 earnings call

Nov 7

Current report 8-K

Financial results

Oct 12

Current report 8-K

Financial results

Aug 3

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $36.04M ▲ 43.8% Net loss $44.05M Diluted EPS -$0.90

Aug 2

Earnings call

Q2 2023 earnings call

Aug 2

Current report 8-K

Financial results

Jul 7

Current report 8-K

Other events

Jun 1

Current report 8-K Events of May 31

Shareholder vote results

May 4

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $33.47M ▲ 9.5% Net loss $43.97M Diluted EPS -$0.90

May 3

Earnings call

Q1 2023 earnings call

May 3

Current report 8-K

Financial results

Apr 13

Proxy statement DEF 14A

Proxy statement

Apr 13

Proxy statement DEFA14A

Proxy statement

Feb 13

Earnings call

Q4 2022 earnings call

Feb 13

Current report 8-K

Financial results, Director or officer change, or executive pay

Feb 13

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $115.38M ▲ 12.4% Net loss $162.96M Diluted EPS -$3.38

Jan 9

Current report 8-K

Financial results, Regulation FD disclosure

Nov 9

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $27.76M ▲ 5.5% Net loss $40.78M Diluted EPS -$0.85

Nov 8

Earnings call

Q3 2022 earnings call

Nov 8

Current report 8-K

Financial results

Nov 4

Current report 8-K Events of Nov 3

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure

Aug 2

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $25.06M ▼ 0.6% Net loss $43.84M Diluted EPS -$0.92

Aug 1

Earnings call

Q2 2022 earnings call

Aug 1

Current report 8-K

Financial results, Other events

Jun 13

Current report 8-K

Financial results, Other events

Jun 1

Current report 8-K Events of May 31

Shareholder vote results

May 5

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $30.55M ▲ 33.3% Net loss $36.89M

May 4

Earnings call

Q1 2022 earnings call